_in_Mizushima,_Japan_256_384.jpg)
News | February 29, 2024
Asahi Kasei offers pharmaceutical excipient Ceolus with nitrite concentration of 0.1 ppm or less
Contributing to lower risk of potentially carcinogenic nitrosamine impurities in pharmaceuticals
Contributing to lower risk of potentially carcinogenic nitrosamine impurities in pharmaceuticals
Survodutide has potential to become best-in-class treatment for metabolic dysfunction-associated steatohepatitis
The observations do not pose any risk to site's compliance standards or its business continuity
Suven Pharmaceuticals’ API and forumulations facilities complete USFDA inspection successfully
Orchid is the first company from India, ever to have invented a product which has received a New Drug Approval (NDA) from USFDA
IOL Chemicals and Pharmaceuticals’ product approved by CDE of NMPA, China
The restructuring aims to create synergies across the business and strengthen capital structure
The Board has elected Dr. Ajit Shetty, who had served as the Company's Interim Chairperson of the Board since December 9, 2023, as Chairperson of the Board, effective February 13, 2024
he lower sales in the current quarter are mainly on account of a one?time impact on the company’s India business
The company is strongly committed to enhancing customer satisfaction and catering to the discerning needs of renowned pharmaceutical companies
Subscribe To Our Newsletter & Stay Updated
